LAUSR

Short half-life doping substances are, quickly eliminated and therefore difficult to control with traditional analytical chemistry methods. Indirect methods targeting biomarkers constitute an alternative to extend detection time frames in doping control analyses. Gene expression analysis (i.e. transcriptomics) has already shown interesting results in both Humans and Equines for erythropoietin (EPO), Growth Hormone (GH) and Anabolic Androgenic Steroid (AAS) misuses. In Humans, circulating cell-free microRNAs in plasma were described as new potential biomarkers for control of Major Doping Agent (MDA) abuses. The development of a qPCR method allowing the detection of circulating miRNAs was carried out on equine plasma collected on different type of tubes (EDTA, Lithium-Heparin). Whereas analyzing plasma collected in EDTA tubes is a standard method in molecular biology, analyzing plasma collected in Lithium-Heparin (LiHep) tubes is challenging, as heparin is a RT-PCR inhibitor. Different strategies were considered and attention was paid on both miRNAs extraction quality and detection sensitivity. The detection of endogenous circulating miRNAs was performed and compared between the different types of tubes. In parallel, homologs of human miRNAs characterized as potential biomarkers of doping were sought in equine databases. The miRNA eca-miR-144, described as potential erythropoiesis stimulating agents (ESAs) administration candidate biomarker was retained and assessed in equine post-administration samples. The results about the qPCR method development and optimization are exposed as well as the equine miRNAs detection. To our knowledge, this work is the first study and the proof of concept of circulating miRNAs detection in plasma dedicated to equine doping control.